MYRIAD GENETICS INC (MYGN) has 5 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 18, 2026 filed Sept. 16, 2026 | Donnelly Brian J Chief Commercial Officer | $0 | 0 | — | No | |
| Sept. 17, 2026 filed Sept. 16, 2026 | Sikri Vishal EVP, Commercial | $0 | 257,731 | +276% | No | |
|
|
||||||
| Sept. 8, 2026 filed Sept. 3, 2026 | Fox Jennifer Lynne Chief Legal Officer | $14,206 | 4,398 | −1% | No | |
|
|
||||||
| Aug. 17, 2026 filed Aug. 16, 2026 | Wheeler Benjamin Richard Chief Financial Officer | $26,546 | 8,761 | −3% | No | |
|
|
||||||
| June 23, 2026 | Skovronsky Daniel Director | $0 | 0 | — | No | |
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free